All Reports Events Blogs Videos
Showing 34 results
  • Blog
    July 08, 2026

    Artificial Intelligence (AI) is having its moment. After years of cautious skepticism, pilot-stage overhang, and boardroom debates, the conversation has moved beyond experimentation. Enterprises are no longer asking whether to deploy agents, they are now asking how fast they can scale them across their entire workflow estate. However, speed comes at a price and almost nobody is doing the math.   The warning signs…
  • Provider Compendium
    Dec. 30, 2025

    Enterprises are repositioning quality from a downstream testing activity to a strategic engineering capability embedded across the software development life cycle. As digital, cloud, and AI initiatives scale, expectations are moving beyond defect identification toward resilience,…
  • LinkedIn Live
    Nov. 19, 2025

    In an evolving landscape where analyst relations (AR) shape market perception and business success, leaders continued to look for proven tactics embraced by experienced AR professionals. Everest Group’s Katrina Menzigian, along with industry experts from other…
  • PEAK Matrix®
    Nov. 13, 2025

    Enterprises are elevating quality from a downstream test phase to a strategic engineering discipline woven through the software development life cycle. As digital, cloud, and AI programs scale, expectations shift from defect detection to resilience, velocity,…
  • Viewpoint
    Nov. 10, 2025

    As enterprises accelerate digital transformation and embrace next-generation technologies such as AI, generative AI, and cloud-native platforms, managing quality at scale has become increasingly complex. Traditional tool-centric quality approaches fall short in addressing fragmented processes, inconsistent…
  • PEAK Matrix®
    Oct. 29, 2025

    Enterprises are reimagining quality as a strategic engineering function rather than a downstream testing activity. As a result, demand for specialized Quality Engineering (QE) services is growing rapidly across industries. This analysis shows how the specialists…
  • Provider Compendium
    Oct. 27, 2025

    The Loyalty Platform – Provider Compendium 2025 provides detailed and fact-based snapshots of 12 loyalty platform providers. Each profile offers a structured overview of the provider’s product and capability focus areas, including platform suite and deployment…
  • Provider Compendium
    Oct. 24, 2025

    The Property and Casualty (P&C) insurance industry is rapidly transforming, driven by volatile market conditions, cost pressures, and increasing operational complexities. As insurers strive for profitable growth and agility, they are reconfiguring core operations and sourcing…
  • Provider Compendium
    Sep. 16, 2025

    Pharmacovigilance (PV) operations have become a strategic priority for life sciences enterprises facing heightened regulatory scrutiny, evolving safety standards, and growing complexity across global markets. This report provides an in-depth assessment of 12 leading PV service…
  • Provider Compendium
    Feb. 20, 2025

    Enterprises are increasingly recognizing their data ecosystem gaps as they strive to fully harness generative AI’s potential. Consequently, they are prioritizing AI-ready data ecosystems, emphasizing robust data management and governance. When scaling their AI initiatives, they…
  • Provider Compendium
    Dec. 12, 2024

    The Procurement Outsourcing (PO) Services – Provider Compendium 2024 offers comprehensive, fact-based profiles of leading PO service providers. The report highlights their service offerings, scale of operations, technology solutions, delivery locations, and recent developments. This report…
  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Provider Compendium
    March 08, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Viewpoint
    Feb. 05, 2024

    In the rapidly evolving life sciences landscape, where the pursuit of innovative therapies and life-saving drugs never ceases, science and technology are increasingly playing a vital role. High-performance Computing (HPC) stands at the forefront of this…
  • PEAK Matrix®
    Jan. 18, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Blog
    June 16, 2023

    Advances in Generative Artificial Intelligence (GAI) have sparked interest in its potential to drive growth and innovation in the biopharma and medical devices industries. Despite challenges and regulations, the life sciences industry is actively exploring GAI’s…
  • State of the Market
    May 31, 2023

    Amid the global COVID-19 pandemic, the Life Sciences (LS) industry faced unprecedented challenges that prompted the accelerated adoption of IT services across its value chain. To ensure business continuity, LS enterprises swiftly embraced virtual ecosystems facilitated…
  • Provider Compendium
    May 03, 2023

    Core administrative operations are a vital component of healthcare plan and payer organizations. However, with the increasing complexity of delivery and implementation options, the legacy Core Administration Processing Solution (CAPS) falls short. The key core administrative…

Items per page